VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%
Wed, 12 Jun

VENUS REMEDIES has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

VENUS REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m93269186425.1%-7.3%
Other incomeRs m3538714.4%1036.2%
TurnoverRs m93569590229.7%-3.6%
ExpensesRs m83864383529.8%-0.4%
Gross profitRs m9447-61-227.8%-164.6%
DepreciationRs m6283830.0%34.1%
InterestRs m98940-100.0%-100.0%
Profit before taxRs m-62-125-105
TaxRs m32-6-1-103.3%
Profit after taxRs m-94-119-104
Gross profit margin%10.16.9-7.0
Effective tax rate%-50.94.41.0
Net profit margin%-10.0-17.2-11.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 7.3% on a year-on-year (YoY) basis. The expenses were down by 0.4% YoY during the same period.
  • The company's operating profit declined by 164.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.0% in 4QFY19 as against 10.1% in 4QFY18.
  • Depreciation charges increased by 34.1% and finance costs declined by 100.0% YoY, respectively.
  • Other income increased by 1036.2% YoY during the quarter.
  • Net profit for the quarter declined by 11.1% YoY. Net profit margins during the quarter declined from -10.0% in 4QFY18 to -11.6% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 25.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 29.8% QoQ during the same period.
  • The company's operating profit declined by 227.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.0% in 4QFY19 as against 6.9% in 3QFY18.
  • Net profit for the quarter increased by 12.7% QoQ, while net profit margins increased from -17.1% in 3QFY18 to -11.6% in 4QFY19.

To see how VENUS REMEDIES has performed over the last eight quarters, please visit here.

VENUS REMEDIES Share Price Performance

Over the last one year, VENUS REMEDIES share price has moved up from Rs 57.1 to Rs 27.4, registering a Loss of Rs 29.7 or around 52.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,132.3 (up 0.0%). Over the last one year it has moved down from 13,755.6 to 13,132.3, a gain of 623 points (down 4.5%).

Overall, the S&P BSE SENSEX is up 12.2% over the year.

Current Valuations

At the current price of Rs 27.4, the price to book value (P/BV) ratio of VENUS REMEDIES stands at 0.1 times.

Equitymaster requests your view! Post a comment on "VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%". Click here!

  

Related Views on News

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of VENUS REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of VENUS REMEDIES. Also includes updates on the valuation of VENUS REMEDIES.

VENUS REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 16.3% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, VENUS REMEDIES has posted a net profit of Rs 8 m (down 16.3% YoY). Sales on the other hand came in at Rs 809 m (down 10.6% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

More Views on News

Most Popular

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

This 20 Year Cycle Suggests Gold is Set for an August Rally(Profit Hunter)

Jul 31, 2020

The real reason why gold prices will go up more.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

VENUS REMEDIES SHARE PRICE


Aug 12, 2020 (Close)

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES 5-YR ANALYSIS

COMPARE VENUS REMEDIES WITH

MARKET STATS